Elon Musk has ambitious plans for Neuralink, projecting that over a thousand patients could be implanted with the device by 2026, and the company is actively hiring to boost production.

The collaboration between Neuralink and Tesla is generating excitement as both companies advance the frontiers of brain-computer interface technology and robotics.

Musk has previously envisioned combining Neuralink technology with robotic limbs, referring to this initiative as the 'Luke Skywalker solution,' inspired by the iconic character from 'Star Wars'.

Despite the promising advancements, Neuralink has faced criticism regarding the ethical implications of its trials, particularly concerning the deaths of animals during testing.

The trial will build on previous successes, as Neuralink has already implanted its device in two patients, including one who demonstrated the ability to play video games and design 3D objects.

Neuralink has received approval for a new feasibility trial, named Convoy, aimed at testing a brain-computer interface (BCI) that enables individuals with paralysis to control a robotic arm using their thoughts.

The University Health Network in Toronto has been selected to perform the neurosurgical procedures for this trial.

Neuralink plans to cross-enroll participants from its ongoing PRIME trial into the new study, although specific details remain limited.

One of Neuralink's primary goals is to restore full body movement for individuals suffering from spinal cord injuries, quadriplegia, or amyotrophic lateral sclerosis (ALS).

The company describes this trial as a crucial step toward achieving both digital and physical freedom for patients.

Unlike traditional BCIs that require wired connections, Neuralink's system operates wirelessly, enhancing usability and user experience.

The N1 implant, a coin-sized device implanted in the brain, captures brain activity and transmits it via Bluetooth, allowing users to navigate a cursor and perform tasks like playing video games.